INNOGENE Co.,Ltd. (KOSDAQ:344860)
South Korea · Delayed Price · Currency is KRW 1,757.00
-4.00 (-0.23%)
At close: Sep 17, 2025
INNOGENE Revenue
INNOGENE had revenue of 1.89B KRW in the quarter ending June 30, 2025, a decrease of -35.49%. This brings the company's revenue in the last twelve months to 7.63B, down -27.47% year-over-year. In the year 2024, INNOGENE had annual revenue of 8.94B, down -11.45%.
Revenue (ttm)
7.63B
Revenue Growth
-27.47%
P/S Ratio
2.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.94B | -1.16B | -11.45% |
| Dec 31, 2023 | 10.10B | 961.65M | 10.52% |
| Dec 31, 2022 | 9.14B | -245.63M | -2.62% |
| Dec 31, 2021 | 9.39B | 3.74B | 66.29% |
| Dec 31, 2019 | 5.64B | -2.16B | -27.72% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |